Our findings demonstrate that DEX exerts its anti-inflammatory effects through activation of the SIRT3/LKB1/AMPK signaling pathway, thereby providing novel mechanistic insights into its therapeutic potential for ALI and other inflammation-related disorders. This evidence concerns the gene PRKAA1 and acute respiratory distress syndrome.